Takeda Pharmaceutical (TAK) Receivables - Net: 2018-2025
Historic Receivables - Net for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $5.1 billion.
- Takeda Pharmaceutical's Receivables - Net rose 4.20% to $5.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $5.1 billion, marking a year-over-year increase of 4.20%. This contributed to the annual value of $5.1 billion for FY2025, which is 1.55% up from last year.
- According to the latest figures from FY2025, Takeda Pharmaceutical's Receivables - Net is $5.1 billion, which was up 1.55% from $5.0 billion recorded in FY2024.
- Over the past 5 years, Takeda Pharmaceutical's Receivables - Net peaked at $7.4 billion during FY2021, and registered a low of -$83.6 million during FY2022.
- In the last 3 years, Takeda Pharmaceutical's Receivables - Net had a median value of $5.0 billion in 2024 and averaged $3.3 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Receivables - Net crashed by 101.12% in 2022, and later surged by 9,252.06% in 2024.
- Over the past 5 years, Takeda Pharmaceutical's Receivables - Net (MRY) stood at $7.4 billion in 2021, then tumbled by 101.12% to -$83.6 million in 2022, then skyrocketed by 34.90% to -$54.5 million in 2023, then skyrocketed by 9,252.06% to $5.0 billion in 2024, then grew by 1.55% to $5.1 billion in 2025.
- Its Receivables - Net stands at $5.1 billion for FY2025, versus $5.0 billion for FY2024 and -$54.5 million for FY2023.